Table 2.
Factors associated with the risk of neurodevelopmental impairment at the last visit
| Patients without neurodevelopmental risk at the last visit (n = 122) | Patients with neurodevelopmental risk at the last visit (n = 45) | p-value | |
|---|---|---|---|
| Distance between household and hospital, km | 29 (12–40) | 35 (20–52) | 0.07 |
| Travel time between household and hospital, min | 41 (20–55) | 46 (31–72) | 0.03 |
|
Delivery: Spontaneous vaginal Assisted vaginal C-section |
48/112 (42.9%) 20/112 (17.8%) 44/112 (39.3%) |
26 (57.8%) 3 (6.7%) 16 (35.5%) |
0.11 |
| Outborn | 3/121 (2.5%) | 3 (6.7%) | 0.35 |
| Age at admission, days | 1 (1–1) | 1 (1–1) | 0.82 |
| Males | 69/121 (43.0%) | 11 (24.4%) | 0.04 |
| Twins | 5 (4.1%) | 0 (0.0%) | 0.33 |
| Apgar score at 5 min | 5 (4–6) | 5 (4–6) | 0.24 |
| Birth weight, gr | 2995 (2662–3308) | 3100 (2730–3300) | 0.47 |
| Body temperature at admission, °C | 35.4 (34.7–36.0) | 35.3 (34.8–35.9) | 0.85 |
| Convulsions | 29 (23.8%) | 21 (46.7%) | 0.007 |
| Meconium (not available in 2019) | 37/82 (45.1%) | 16/28 (57.1%) | 0.38 |
| IV fluids | 70 (57.4%) | 34 (75.6%) | 0.04 |
| Antibiotic therapy | 117 (95.9%) | 42 (93.3%) | 0.78 |
| Respiratory distress | 80 (65.6%) | 39 (86.7%) | 0.01 |
| Oxygen therapy, days | 2 (1–6) | 5 (2–13) | 0.004 |
| Length of hospital stay, days | 8 (7–11) | 12 (8–17) | 0.0007 |
| Inappropriate growth | 35 (28.7%) | 28 (62.2%) | 0.0002 |
Data summarised as n (%) or median (IQR)